The PI3K inhibitor, taselisib, has a unique mechanism of action that leads to enhanced potency in PIK3CA mutant models

被引：3
|
作者：
Song, Kyung W.
Edgar, Kyle A.
Kirkpatrick, Donald S.
Phu, Lilian
Schmidt, Stephen
Nannini, Michelle
Hong, Rebecca
Cheng, Eric
Crocker, Lisa
Young, Amy
Sampath, Deepak
Friedman, Lori
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-146
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
146
引用
收藏
页数：2
相关论文
共 50 条
  • [21] PI3K expression and PIK3CA mutations are related to colorectal cancer metastases
    Yu-Fen Zhu
    World Journal of Gastroenterology, 2012, (28) : 3745 - 3751
  • [22] Selective degradation of mutant PIK3CA promotes increased mutant specificity in a subset of PI3K ATP-competitive inhibitors
    Nguyen, Lan
    Edgar, Kyle
    Song, Kyung
    Schmidt, Stephen
    Schutz, Victorai
    Ishisoko, Noriko
    Torres, Eric
    Das, Akash
    Murali, Divya
    Sideris, Steve
    Wendorff, Timothy
    Saabye, Matt
    Purkey, Hans
    Sudhamsu, Jawahar
    Staben, Steven
    Hanan, Emily
    Hatzivassiliou, Georgia
    Friedman, Lori
    Endres, Nicholas F.
    MOLECULAR CANCER RESEARCH, 2020, 18 (10) : 43 - 43
  • [23] Taselisib (GDC-0032), a Potent β-Sparing Small Molecule Inhibitor of PI3K, Radiosensitizes Head and Neck Squamous Carcinomas Containing Activating PIK3CA Alterations
    Zumsteg, Zachary S.
    Morse, Natasha
    Krigsfeld, Gabriel
    Gupta, Gaorav
    Higginson, Daniel S.
    Lee, Nancy Y.
    Morris, Luc
    Ganly, Ian
    Shiao, Stephan L.
    Powell, Simon N.
    Chung, Christine H.
    Scaltriti, Maurizio
    Baselga, Jose
    CLINICAL CANCER RESEARCH, 2016, 22 (08) : 2009 - 2019
  • [24] Understanding PI3K inhibitor mechanism of action
    Sarah Crunkhorn
    Nature Reviews Drug Discovery, 2021, 20 (11) : 816 - 816
  • [25] PRECLINICAL DEVELOPMENT OF THE PI3K ALPHA SELECTIVE AND PIK3CA MUTANT SELECTIVE INHIBITOR GDC-0077 AND PREDICTION OF ITS HUMAN PHARMACOKINETICS
    Pang, Jodie
    Baumgardner, Matthew
    Braun, Marie-Gabrielle
    Cheong, Jonathan
    Edgar, Kyle
    Friedman, Lori
    Hanan, Emily
    Jaochico, Allan
    Ma, Shuguang
    Plise, Emile
    Schmidt, Stephen
    Liu, Ning
    Song, Kyung
    Staben, Steve
    Salphati, Laurent
    DRUG METABOLISM AND PHARMACOKINETICS, 2019, 34 (01) : S37 - S37
  • [26] Co-alterations in PIK3CA and ARID1A lead to enhanced sensitivity to PI3K inhibition
    Udgata, Shirsa
    Stoecker, Jordan N.
    Lippert, Anna L.
    Pasch, Cheri A.
    Deming, Dustin A.
    CANCER RESEARCH, 2024, 84 (06)
  • [27] Double PIK3CA mutations in cis enhance PI3Kα oncogene activation and sensitivity to PI3Kα inhibitors in breast cancer
    Vasan, N.
    Razavi, P.
    Johnson, J. L.
    Shao, H.
    Reznik, E.
    Smith, M. L.
    Sebra, R.
    Cantley, L. C.
    Scaltriti, M.
    Baselga, J.
    ANNALS OF ONCOLOGY, 2019, 30 : 1 - 1
  • [28] Activation of the PI3K/AKT pathway and PIK3CA mutations in Merkel cell carcinoma
    Hafner, C.
    Houben, R.
    Baeurle, A.
    Landthaler, M.
    Becker, J. C.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2010, 8 (09): : 739 - 739
  • [29] Double PIK3CA mutations in cis increase oncogenicity and sensitivity to PI3Kα inhibitors
    Vasan, Neil
    Razavi, Pedram
    Johnson, Jared L.
    Shao, Hong
    Shah, Hardik
    Antoine, Alesia
    Ladewig, Erik
    Gorelick, Alexander
    Lin, Ting-Yu
    Toska, Eneda
    Xu, Guotai
    Kazmi, Abiha
    Chang, Matthew T.
    Taylor, Barry S.
    Dickler, Maura N.
    Jhaveri, Komal
    Chandarlapaty, Sarat
    Rabadan, Raul
    Reznik, Ed
    Smith, Melissa L.
    Sebra, Robert
    Schimmoller, Frauke
    Wilson, Timothy R.
    Friedman, Lori S.
    Cantley, Lewis C.
    Scaltriti, Maurizio
    Baselga, Jose
    CANCER RESEARCH, 2020, 80 (16)
  • [30] Determinants of sensitivity to PI3K inhibitors in PIK3CA wildtype gastric tumor cells
    Chong, Mei Ling
    Bhattacharya, Bhaskar
    Voon, Dominic
    Ko, King Xin
    Low, Hong Hui
    Chang, Ti Ling
    Wu, Mengchu
    Tan, Patrick Boon Ooi
    Loh, Marie Chiew Shia
    Benoukraf, Touati
    Huynh The Hung
    Politz, Oliver
    Liu, Ningshu
    Soong, Richie Chuan Teck
    CANCER RESEARCH, 2015, 75
12345